Received Jan 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
raging case of shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. In NOV-2021, the patient received the 1st dose of Shingles vaccine. In NOV-2021, 2 weeks after receiving Shingles vaccine, the patient experienced shingles (Verbatim: raging case of shingles). The outcome of the shingles was not resolved. It was unknown if the reporter considered the shingles to be related to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 11-JAN-2026 The case was received form the patient via interactive digital media. The patient reported that still having experienced symptoms on the day of reporting. The batch number was not provided, and unable to contact the reporter.